Michigan Ear Institute, Farmington Hills.
St. John Providence Hospital, Southfield, Michigan.
Otol Neurotol. 2018 Apr;39(4):451-457. doi: 10.1097/MAO.0000000000001736.
To assess differences in the incidence, type, and management of complications encountered with implantation of percutaneous osseointegrated bone conduction devices when using a 9 mm abutment versus 6 mm abutment at initial implantation.
Retrospective cohort study.
One hundred thirty consecutive patients between January 2010 and December 2011 underwent single-stage percutaneous osseointegrated bone conduction device implantation using a 9 or 6 mm abutment. Clinical outcomes assessed for the two groups included the incidence, type, and management of postoperative complications. Abutment size, age, sex, indication for surgery, implant device type, duration of follow-up, and patient comorbidities were evaluated as potential factors affecting outcomes.
Average duration of follow-up was 16 months (range 6-29 mo). Postoperative complications occurred in 38 (29.2%) patients. Twenty-four (18.4%) patients experienced minor complications requiring simple, local care; eight (6.1%) patients required in-office procedural intervention; and six (4.6%) patients required revision surgery in the operating room. Implant extrusion occurred in three (2.3%) patients. Eleven (8.5%) patients required placement of a longer abutment. Patients receiving the 6 mm abutment at initial surgery were significantly more likely to encounter a complication requiring in-office procedural intervention or revision surgery (p = 0.001).
Minor complications after implantation of percutaneous osseointegrated bone conduction devices are common. The vast majority of these complications are due to localized skin reactions, most of which are readily addressed through local care. Patients receiving the 9 mm abutment during initial implantation are significantly less likely to require in-office procedural intervention or revision surgery postoperatively as compared with those receiving the shorter, 6 mm abutment.
评估在初始植入时使用 9mm 接杆与 6mm 接杆对经皮骨整合骨导装置植入后并发症的发生率、类型和处理方式的差异。
回顾性队列研究。
2010 年 1 月至 2011 年 12 月,130 例连续患者接受了单阶段经皮骨整合骨导装置植入术,使用 9 或 6mm 接杆。对两组的临床结果评估包括术后并发症的发生率、类型和处理方式。评估了接杆尺寸、年龄、性别、手术指征、植入物设备类型、随访时间和患者合并症等潜在因素对结果的影响。
平均随访时间为 16 个月(范围 6-29 个月)。术后并发症发生在 38 例(29.2%)患者中。24 例(18.4%)患者出现需要简单局部护理的轻微并发症;8 例(6.1%)患者需要在办公室进行程序性干预;6 例(4.6%)患者需要在手术室进行修正手术。有 3 例(2.3%)患者发生植入物挤出。11 例(8.5%)患者需要放置更长的接杆。在初始手术中接受 6mm 接杆的患者更有可能发生需要办公室程序性干预或修正手术的并发症(p=0.001)。
经皮骨整合骨导装置植入后的轻微并发症很常见。绝大多数这些并发症是由于局部皮肤反应引起的,其中大多数通过局部护理很容易解决。与接受较短的 6mm 接杆的患者相比,在初始植入时接受 9mm 接杆的患者术后接受办公室程序性干预或修正手术的可能性显著降低。